These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7731937)
41. Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma? Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S38-47. PubMed ID: 1575219 [TBL] [Abstract][Full Text] [Related]
42. Prognostic relevance of cell proliferation in major salivary gland carcinomas. Suzzi MV; Alessi A; Bertarelli C; Cancellieri A; Procaccio L; Dall'olio D; Laudadio P Acta Otorhinolaryngol Ital; 2005 Jun; 25(3):161-8. PubMed ID: 16450771 [TBL] [Abstract][Full Text] [Related]
43. Renal cell (Grawitz) carcinoma: an immunohistochemical study in correlation with nuclear grade, histological pattern and proliferative activity of tumor cells. Nagar C; Tralongo V; Morello V; Salvato M; Curti Giardina M; Latteri MA; Nuara R; Arena N; Vita C; Orestano F Pathologica; 1993; 85(1097):343-52. PubMed ID: 7694227 [TBL] [Abstract][Full Text] [Related]
44. Relationships between image cytometric DNA index, proliferation fraction and multiploidy and conventional nuclear grade in breast carcinoma. Smith FB; Zappi ME Mod Pathol; 1993 Sep; 6(5):606-11. PubMed ID: 7504261 [TBL] [Abstract][Full Text] [Related]
45. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas. Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301 [TBL] [Abstract][Full Text] [Related]
46. Nuclear DNA measurements in squamous cell carcinoma of the lung: a guide for prognostic evaluation. Blöndal T; Bengtsson A Anticancer Res; 1981; 1(2):79-86. PubMed ID: 7051956 [TBL] [Abstract][Full Text] [Related]
47. Correlation between immunohistochemical expression of proliferating cell nuclear antigen and flow cytometry parameters in colorectal neoplasia. Lazaris AC; Davaris P; Nakopoulou L; Theodoropoulos GE; Koullias G; Golematis BC Dis Colon Rectum; 1994 Nov; 37(11):1083-9. PubMed ID: 7956574 [TBL] [Abstract][Full Text] [Related]
48. Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival. Shameem IA; Shimabukuro T; Wada T; Kurisu H; Naito K Eur Urol; 1996; 29(1):78-84. PubMed ID: 8821696 [TBL] [Abstract][Full Text] [Related]
49. [Comparison of flow-cytometry and immunohistochemistry with proliferating monoclonal antibody. Cell nuclear antigen (PCNA) in the study of proliferative kinetics of renal carcinoma]. Villari D; Iannelli F; Li Marzi V; Marzocco M; Amorosi A; Trippitelli A; Nicita G Arch Ital Urol Androl; 1997 Feb; 69 Suppl 1():33-7. PubMed ID: 9181920 [TBL] [Abstract][Full Text] [Related]
50. [Qualitative and quantitative parameters for prognosis in renal carcinoma in early and advanced stages]. Del Vecchio MT; Spina D; Lazzi S; Bruni A; Funtò I; Mattei FM; Fornaini M; Luzi P; Tosi P Pathologica; 1997 Aug; 89(4):390-6. PubMed ID: 9471607 [TBL] [Abstract][Full Text] [Related]
51. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7. Amare Kadam PS; Varghese C; Bharde SH; Narasimhamoorthy NK; Desai S; Advani SH; Havaldar R; Kulkarni JN Cancer Genet Cytogenet; 2001 Mar; 125(2):139-46. PubMed ID: 11369057 [TBL] [Abstract][Full Text] [Related]
53. DNA and PCNA content of renal cell carcinoma and prognosis. Flint A; Grossman HB; Liebert M; Lloyd RV; Bromberg J Am J Clin Pathol; 1995 Jan; 103(1):14-9. PubMed ID: 7817936 [TBL] [Abstract][Full Text] [Related]
54. Renal cell carcinoma: comparison of morphological and flow cytometric parameters of primary tumour and invasive tumour lying within the renal vein. Novelli MR; MacIver AG J Pathol; 1992 Jun; 167(2):229-33. PubMed ID: 1635003 [TBL] [Abstract][Full Text] [Related]
55. The significance of angiogenesis and tumoral proliferation in renal cell carcinoma. Puşcaşiu D; Tatu C; Tatu RF; Potencz E; Popescu R; Muntean I; Verdeş D Rom J Morphol Embryol; 2011; 52(1 Suppl):369-72. PubMed ID: 21424076 [TBL] [Abstract][Full Text] [Related]
57. [Prognosis factors in adenocarcinoma of the kidney. II. Microscopic factors]. Gutiérrez JL; Val-Bernal JF; Portillo JA; Garijo F; Buelta L Arch Esp Urol; 1990 Jun; 43(5):489-93. PubMed ID: 2389973 [TBL] [Abstract][Full Text] [Related]
58. Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases. Grignon DJ; Ayala AG; el-Naggar A; Wishnow KI; Ro JY; Swanson DA; McLemore D; Giacco GG; Guinee VF Cancer; 1989 Nov; 64(10):2133-40. PubMed ID: 2804902 [TBL] [Abstract][Full Text] [Related]
59. Flow cytometric analysis of DNA ploidy, cell cycle and cytomorphometry in sarcomatoid renal cell carcinoma. Yu DS; Wang J; Chang SY; Ma CP Eur Urol; 1991; 20(3):227-31. PubMed ID: 1823046 [TBL] [Abstract][Full Text] [Related]
60. Malignancy index based on flow cytometry and histology for renal cell carcinomas and its correlation to prognosis. Baisch H; Otto U; Klöppel G Cytometry; 1986 Mar; 7(2):200-4. PubMed ID: 3948608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]